— Know what they know.
Not Investment Advice

0QLN.L

Tecan Group AG
1W: +4.4% 1M: -4.1% 3M: -8.4% YTD: -5.1% 1Y: -38.8% 3Y: -66.4% 5Y: -69.7%
CHF 126.40 ($159.60)
-0.20 (-0.16%)
 
LSE · Healthcare · Medical - Pharmaceuticals · CHF 1.6B
Smart Money Score
No convergence signal
Key Statistics
Market CapCHF 1.6B ($2.0B)
52W Range126.3-412.6
Volume18,942
Avg Volume7,876
Beta1.25
DividendCHF 3.00
Analyst Ratings
No analyst coverage
Company Info
CEOMonica Manotas
Employees3,074
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2014-07-31
Websitetecan.com
Seestrasse 103
Männedorf 8708
CH
41 44 922 88 88
About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms